Skip to main content

Peer Review reports

From: Laquinimod efficacy in relapsing-remitting multiple sclerosis: how to understand why and if studies disagree

Original Submission
26 Jan 2016 Submitted Original manuscript
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 2
Submitted Manuscript version 2
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Author responded Author comments
Reviewed Reviewer Report
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
12 Sep 2016 Editorially accepted
17 Sep 2016 Article published 10.1186/s12883-016-0702-4

You can find further information about peer review here.

Back to article page